These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 22284336)
41. Nonenhancing breast malignancies on MRI: sonographic and pathologic correlation. Ghai S; Muradali D; Bukhanov K; Kulkarni S AJR Am J Roentgenol; 2005 Aug; 185(2):481-7. PubMed ID: 16037524 [TBL] [Abstract][Full Text] [Related]
42. [Role of cytokeratin expression in differential diagnosis of intraductal proliferative lesions of breast]. Zhang JL; Zhang HY; Wei B; Lang ZQ; Bu H Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):316-9. PubMed ID: 15363314 [TBL] [Abstract][Full Text] [Related]
43. Magnetic resonance mammography in small vs. advanced breast lesions - systematic comparison reveals significant impact of lesion size on diagnostic accuracy in 936 histologically verified breast lesions. Dietzel M; Baltzer PA; Vag T; Gröschel T; Richter C; Burmeister H; Kaiser WA Rofo; 2011 Feb; 183(2):126-35. PubMed ID: 20830650 [TBL] [Abstract][Full Text] [Related]
44. Breast augmentation and the risk of subsequent breast cancer. Hall FM N Engl J Med; 1993 Mar; 328(9):662; author reply 663. PubMed ID: 8381521 [No Abstract] [Full Text] [Related]
45. [Diagnosis and treatment of occult breast cancer: report of 23 cases]. Zhong Y; Sun Q; Huang HY; Zhou YD; Guan JH; Mao F; Lin Y; Xu YL Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):716-8. PubMed ID: 21122392 [TBL] [Abstract][Full Text] [Related]
46. Diagnostic accuracy of fiberoptic ductoscopy plus in vivo iodine staining for intraductal proliferative lesions. Feng XZ; Song YH; Zhang FX; Jiang CW; Mei H; Zhao B Chin Med J (Engl); 2013 Aug; 126(16):3124-9. PubMed ID: 23981624 [TBL] [Abstract][Full Text] [Related]
47. Patient age and preoperative breast MRI in women with breast cancer: biopsy and surgical implications. Adkisson CD; Vallow LA; Kowalchik K; McNeil R; Hines S; Deperi E; Moreno A; Roy V; Perez EA; McLaughlin SA Ann Surg Oncol; 2011 Jun; 18(6):1678-83. PubMed ID: 21207171 [TBL] [Abstract][Full Text] [Related]
48. Breast cancer in reduction mammoplasty: case reports and a survey of plastic surgeons. Jansen DA; Murphy M; Kind GM; Sands K Plast Reconstr Surg; 1998 Feb; 101(2):361-4. PubMed ID: 9462767 [TBL] [Abstract][Full Text] [Related]
49. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. Liberman L; Morris EA; Dershaw DD; Abramson AF; Tan LK AJR Am J Roentgenol; 2003 Apr; 180(4):901-10. PubMed ID: 12646427 [TBL] [Abstract][Full Text] [Related]
50. Symmetrization reduction mammaplasty combined with sentinel node biopsy in patients operated for contralateral breast cancer. Schrenk P; Wölfl S; Bogner S; Huemer GM; Wayand W J Surg Oncol; 2006 Jul; 94(1):9-15. PubMed ID: 16788937 [TBL] [Abstract][Full Text] [Related]
51. [In situ ductal carcinoma of the breast: a diagnostic challenge]. Fuchsjäger MH; Helbich TH Wien Med Wochenschr Suppl; 2002; (113):69-73. PubMed ID: 12621847 [TBL] [Abstract][Full Text] [Related]
52. MR mammography is useful in the preoperative locoregional staging of breast carcinomas with extensive intraductal component. Van Goethem M; Schelfout K; Kersschot E; Colpaert C; Verslegers I; Biltjes I; Tjalma WA; De Schepper A; Weyler J; Parizel PM Eur J Radiol; 2007 May; 62(2):273-82. PubMed ID: 17223002 [TBL] [Abstract][Full Text] [Related]
53. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology. Monti S; Galimberti V; Trifiro G; De Cicco C; Peradze N; Brenelli F; Fernandez-Rodriguez J; Rotmensz N; Latronico A; Berrettini A; Mauri M; Machado L; Luini A; Paganelli G Ann Surg Oncol; 2007 Oct; 14(10):2928-31. PubMed ID: 17674108 [TBL] [Abstract][Full Text] [Related]
54. Added Value of Breast MRI for Preoperative Diagnosis of Ductal Carcinoma In Situ: Diagnostic Performance on 362 Patients. Petrillo A; Fusco R; Petrillo M; Triunfo F; Filice S; Vallone P; Setola SV; Rubulotta M; Di Bonito M; Rinaldo M; D'Aiuto M; Brunetti A Clin Breast Cancer; 2017 Jun; 17(3):e127-e134. PubMed ID: 28111130 [TBL] [Abstract][Full Text] [Related]
55. Occult breast cancer during reduction mammoplasty: case report. Panizzo N; D'Aloja C; Scomersi S; Papa G; Bortul M; Arnez ZM Ann Ital Chir; 2013 Feb; 84(ePub):. PubMed ID: 23474433 [TBL] [Abstract][Full Text] [Related]
56. Breast magnetic resonance imaging for preoperative locoregional staging. Hollingsworth AB; Stough RG; O'Dell CA; Brekke CE Am J Surg; 2008 Sep; 196(3):389-97. PubMed ID: 18436185 [TBL] [Abstract][Full Text] [Related]
58. Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate? Punglia RS; Schnitt SJ; Weeks JC J Natl Cancer Inst; 2013 Oct; 105(20):1527-33. PubMed ID: 24068769 [TBL] [Abstract][Full Text] [Related]
59. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening? Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971 [TBL] [Abstract][Full Text] [Related]
60. Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy? McLaughlin SA; Stempel M; Morris EA; Liberman L; King TA Cancer; 2008 Mar; 112(6):1214-21. PubMed ID: 18257089 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]